Loading organizations...

Leimerious Capital operates as a venture capital and private equity firm, primarily focused on providing financial backing and strategic support to early and growth-stage enterprises. The firm constructs diversified investment partnerships, such as the Tibet Leimerious Venture Investment Partnership, which are designed to identify and cultivate high-potential companies across various sectors, including notable investments in biotechnology. Its core activity involves deploying capital into promising innovations, guiding portfolio companies through critical development phases with a structured investment approach.
Established in 2016, Leimerious Capital emerged from a recognition of the significant market opportunities present in China’s rapidly evolving startup and growth company landscape. Based in Chengdu, Sichuan, the firm strategically positions itself to tap into regional innovation hubs and emerging industries. This foundational insight drives its commitment to nurturing businesses that demonstrate strong growth trajectories and disruptive potential within their respective markets.
The firm's portfolio comprises innovative startups and developing companies seeking strategic capital infusions to scale operations and accelerate market penetration. Leimerious Capital's overarching vision is to be a catalyst for economic advancement by fostering the development of pioneering companies. It aims to contribute to the long-term success of its portfolio, thereby driving industry evolution and generating sustainable value across its investment ecosystem.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 16, 2020 | Enzymaster | $7.5M Series B | — | Caozhixing Junbo Equity Investment Partnership, Weifang Zhongke Haichuang Equity Investment Partnership |